Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computerized drug-use evaluation

H M O'Connell1, S Chance, L Bowman

  • 1Margaret's Mercy Healthcare Centers, Hammond, IN.

American Journal of Hospital Pharmacy
|February 1, 1994
PubMed
Summary

A drug-use evaluation compared manual and computerized methods for assessing angiotensin-converting-enzyme (ACE) inhibitor use. Computerized drug-use evaluations showed similar results to manual reviews, particularly for straightforward criteria.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of, and Gender Differences in College Students' Experiences of Alcohol-Related Regretted Sex: a Scoping Review.

Current addiction reports·2026
Same author

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

European heart journal·2021
Same author

Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-25].

European journal of cancer (Oxford, England : 1990)·2018
Same author

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study.

European journal of cancer (Oxford, England : 1990)·2017
Same author

Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics.

American heart journal·2017
Same author

Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Clinical pharmacology and therapeutics·2015

Failed At:

2026-07-14T07:44:41.393463+00:00

Related Experiment Videos